ROCK inhibitor RKI-1313, Purity ≥98%

Synonym: 1342276-76-9; RKI-1313; 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea; 1-[(3-Methoxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea; RKI 1313; 1-[(3-Methoxyphenyl)methyl]-3-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]urea; ROCK inhibitor

MDL: MFCD27996044
CAS Number: 1342276-76-9
Compound CID: 53492330

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

RKI-1313 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity.

Molecular Weight

340.401

Molecular Formula

C₁₇H₁₆N₄O₂S

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

RKI-1313 can be used to study its inhibitory effects on Rho kinase and its potential therapeutic benefits in cardiovascular diseases.

Storage

Store at -20ºC.